Member Directory

ENA Respiratory Pty Ltd

Website: https://enarespiratory.com/

Member Contact: Dr Christophe Demaison

Position: Chief Executive Officer

Industry: Biotech & Pharmaceuticals

Company Profile:

ENA Respiratory is a clinical stage, biotechnology company based in Melbourne. The company aims to transform the prevention of COVID-19 and other respiratory viral infections in populations at risk of severe complications. A spin-off of ENA Therapeutics (now renamed Axelia Oncology), ENA secured in March 2021, AU$32m Series A investment from the Minderoo Foundation, Brandon Capital Partners and Uniseed.

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.